Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.
Kennedy, Leanne D
Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome. [electronic resource] - Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners Sep 2010 - 205-13 p. digital
Publication Type: Journal Article; Review
1477-092X
10.1177/1078155209348719 doi
Allopurinol--therapeutic use
Antineoplastic Agents--adverse effects
Gout Suppressants--therapeutic use
Hematologic Neoplasms--drug therapy
Humans
Hyperuricemia--drug therapy
Infusions, Intravenous
Tumor Lysis Syndrome--drug therapy
Urate Oxidase--therapeutic use
Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome. [electronic resource] - Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners Sep 2010 - 205-13 p. digital
Publication Type: Journal Article; Review
1477-092X
10.1177/1078155209348719 doi
Allopurinol--therapeutic use
Antineoplastic Agents--adverse effects
Gout Suppressants--therapeutic use
Hematologic Neoplasms--drug therapy
Humans
Hyperuricemia--drug therapy
Infusions, Intravenous
Tumor Lysis Syndrome--drug therapy
Urate Oxidase--therapeutic use